Navigation Links
Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator
Date:1/30/2008

Vivian Cheung, M.D., a pediatric neurologist at The Childrens Hospital of Philadelphia and the University of Pennsylvania School of Medicine, has been named a Howard Hughes Medical Institute (HHMI) investigator. Following a nationwide competition in 2007, Cheung was one of 15 physician-scientists selected recently by the prestigious research organization.

Like all those chosen, Dr. Cheung focuses on translating research discoveries into improved medical treatments.

We are extremely pleased and proud of the fact that one of our pediatricians was honored by one of the worlds leading biomedical research institutions, said Philip R. Johnson, M.D., chief scientific officer and senior vice president of Children's Hospital. This appointment recognizes Dr. Cheungs accomplishments in advancing genetic discovery.

Cheung investigates how the sequence of DNA units in a persons chromosomes affects that persons susceptibility to disease. She uses microarray technology to rapidly measure how strongly genes are expressed within cells. By determining how gene expression changes in response to drugs and other treatments, she discovers how each patients DNA variations are associated with the effectiveness of their disease treatments.

Her goal is to help physicians predict how a patient will respond to a given drug or treatment, based on the patients particular genetic profile. Ultimately, providing refined genetic tools may remove some of the guesswork in making treatment decisions and in providing the best preventive and therapeutic care.

Trained in neurology, Cheung has a specific interest in a neurogenetic disease called ataxia telangiectasia, which affects movement, muscle control, the immune system and susceptibility to cancer. Because different children may react very differently to their treatments, her research aims to customize treatment to a patients genetic profile, thus minimizing side effects and providing maximum benefits. Cheungs studies could be applied to a broad range of common and uncommon diseases, in using genetic tools to eventually routinely guide physicians and patients to better treatments.

As a pediatrician at Childrens Hospital, Cheung is continuing to work at the Hospital and has become an employee of HHMI, which provides a research budget and funding for laboratory space. Cheung remains an associate professor of Pediatrics and Genetics at the University of Pennsylvania School of Medicine.

After earning her M.D. degree from Tufts University School of Medicine, Cheung completed her residency at the UCLA Medical Center, before coming to The Childrens Hospital of Philadelphia in 1996. She holds the William Wikoff Smith Endowed Chair in Pediatric Genomic Research at Childrens Hospital, where she leads an NIH-funded laboratory.


'/>"/>

Contact: John Ascenzi
ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert  

Related medicine news :

1. Interleukin Genetics, Inc. Management to Present at Healthcare Conferences
2. Genetics May Determine Antidepressants Effectiveness
3. Genetics Influence Blood Pressure Medications
4. People with anorexia less likely to be blamed when biology, genetics explained
5. Top10 research advances include studies on genetics and stem cell research, stents
6. Heart attack risk from smoking due to genetics
7. Genetics May Boost Mexican-Americans Risk for Alcoholism
8. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
9. Researchers develop powerful tool to study the genetics of inflammation
10. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
11. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
(Date:6/24/2016)... ... June 24, 2016 , ... Southern Illinois University School ... for the Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy (MOM). They ... Center in Collinsville. , They expect to treat approximately 2,000 patients ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... WASHINGTON , June 23, 2016  The ... Pharmaceuticals has joined the health policy research organization ... Steven Romano , MD, senior vice president and ... his company,s representative on the NPC Board of ... are pleased that Mallinckrodt has joined us in ...
Breaking Medicine Technology: